Abstract | ETHNOPHARMACOLOGY RELEVANCE: Our previous study showed that the proteoglycan P1 from Phellinus linteus (Mesima) exhibits significant anti- tumor activity against human hepatocellular carcinoma cells (HepG2); however, its molecular mechanism remains unknown. This study aims to provide insights into the mechanism of the anti- tumor activity of P1 against HepG2 cells. METHODS: We examined the effects of P1 on HepG2 cell proliferation in vitro and in vivo. Flow cytometry was used to analyze the cell cycle distribution and apoptosis. Proteomic analysis, real-time (RT)-PCR, and Western blot were carried out to observe the expression of several cell cycle control proteins in HepG2 cells. RESULTS: Both the volume and the weight of solid tumors were significantly decreased in P1-treated mice (200mg/kg) compared with the control. The HepG2 cells in the P1-treated tumors were significantly decreased, irregularly shaped, and smaller. P1 slightly increased the body weight of the tumor-bearing mice, which indicates that P1 is nontoxic to mammals at 200mg/kg. P1 also caused a significant dose-dependent increase in S phase arrest, but no apoptosis was observed in HepG2 cells. The results of the proteomic analysis, RT-PCR, and Western blot analysis showed that significantly downregulated expression of calreticulin, cyclin D1, cyclin E, and CDK2 and upregulated expression of P27 kip1 and cyclin A in the P1-treated HepG2 cells (200 μg/ml). CONCLUSION: These results suggest that calreticulin expression and the P27 kip1-cyclin A/D1/E-CDK2 pathway were involved in P1-induced S-phase cell cycle arrest in HepG2 cells.
|
Authors | You-Gui Li, Dong-Feng Ji, Shi Zhong, Pei-Gang Liu, Zhi-Qiang Lv, Jian-Xun Zhu, Jin-E Chen, Hua-Ping Chen |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 150
Issue 1
Pg. 187-95
(Oct 28 2013)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 24001891
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Calreticulin
- Cyclins
- Fungal Polysaccharides
- Cyclin-Dependent Kinase Inhibitor p27
- CDK2 protein, human
- Cyclin-Dependent Kinase 2
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Basidiomycota
- Calreticulin
(metabolism)
- Cell Proliferation
(drug effects)
- Cyclin-Dependent Kinase 2
(metabolism)
- Cyclin-Dependent Kinase Inhibitor p27
(metabolism)
- Cyclins
(metabolism)
- Female
- Fungal Polysaccharides
(pharmacology, therapeutic use)
- Hep G2 Cells
- Humans
- Mice
- Mice, Nude
- Proteomics
- S Phase
(drug effects)
- Xenograft Model Antitumor Assays
|